WuXi Partners with Pacific Biomarkers

We are pleased to announce a biomarker collaboration with Pacific Biomarkers (PBI), a premier biomarker laboratory services provider based in Seattle. Biomarkers are a new and important tool in the development of...

WuXi Genome Center Purchases an Illumina HiSeq X Ten Sequencing System

WuXi is pleased to announce that we have purchased an Illumina HiSeq X Ten sequencing system for the WuXi Genome Center.  This new investment will enhance WuXi’s clinical genomic services from...

WuXi Successfully Hosts 2nd Annual WuXi Global Forum – A Video Summary

Thanks to our esteemed speakers, and great industry support and participation, WuXi Global Forum 2014 was a great success. We created a couple of short videos to capture those special and...

WuXi Corporate Venture Fund Invests in Innovative Cancer Imaging Business

We are delighted to share with you that  WuXi Corporate Venture Fund has contributed to a $6.85 million Series B round financing of Avelas Biosciences, Inc., a San Diego-based biotech that is developing an...

WuXi Global Forum 2014

2013 has been a great year in the world of pharma and biotech R&D. While we are still facing mounting productivity challenges, many have come to understand that no single company –...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

A Futuristic Biopharma Company Addressing Some of the World’s Biggest Health...

By Rich Soll, Senior Advisor, Strategic Initiatives at WuXi AppTec (@richsollwx) For the past few years, PureTech Health has been building a new R&D model for advancing breakthrough...